BRAF and neoplasm: High-fucosylation tumours exhibited elevated epithelial differentiation, MSI-H/<i>BRAF</i>-mutant enrichment, oxidative phosphorylation dominance, the complete absence of EMT and invasion programmes, and favourable prognosis (HR = 0.633, 95% CI: 0.470-0.853, <i>p</i> = 0.003).